HomeSPRO • NASDAQ
add
Spero Therapeutics Inc
Previous close
$1.50
Day range
$1.46 - $1.55
Year range
$0.99 - $2.00
Market cap
79.19M USD
Avg Volume
440.05K
P/E ratio
3.42
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 73.52M | 54.98% |
Operating expense | 6.43M | -0.95% |
Net income | 51.19M | 91.22% |
Net profit margin | 69.63 | 23.39% |
Earnings per share | 0.96 | 0.00% |
EBITDA | 50.57M | 94.60% |
Effective tax rate | 0.75% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 76.33M | -30.04% |
Total assets | 182.39M | 46.14% |
Total liabilities | 75.50M | 54.49% |
Total equity | 106.89M | — |
Shares outstanding | 53.87M | — |
Price to book | 0.74 | — |
Return on assets | 87.28% | — |
Return on capital | 146.92% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 51.19M | 91.22% |
Cash from operations | -17.49M | -139.33% |
Cash from investing | — | — |
Cash from financing | 1.00K | -99.99% |
Net change in cash | -17.49M | -129.82% |
Free cash flow | -1.18M | -105.30% |
About
Founded
2013
Website
Employees
46
